Clinical Trials in Georgia

Showing 3121-3140 of 14,426 trials

A Study of LY3549492 in Healthy Weight Adult Participants

NCT07085468

The main purpose of this study is to evaluate the safety and tolerability of LY3549492 in adult participants with a healthy body max index (BMI) of 22 to 25 kilograms per square meter (kg/m2). Participation in the study will last about 13 months.

Healthy

Eli Lilly and Company1 participantsStarted Jul 2025

Scottsdale, Arizona, United States • Covina, California, United States • Northridge, California, United States +18 more locations

Active Not RecruitingPhase 363 miles

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

NCT04437511

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease. Additional participants will be enrolled to an addendum safety cohort. The participants will be administered open-label donanemab. Trial participants who were dosed with donanemab in the main study will be enrolled to a 3-year follow up addendum. No study drug will be administered during this follow up.

Alzheimer Disease

Eli Lilly and Company1,736 participantsStarted Jun 2020

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +271 more locations

A Study of LY3549492 in Healthy Weight Adult Participants

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Find Trials by Condition in Georgia

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Long-Term Evaluation of BIIB067 (Tofersen)

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

HPC Offered for PRESERVE Expansion

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)